Cibus shares surge 10.64% premarket after signing non-binding LOI with Interoc to commercialize herbicide-tolerant rice traits in Latin America.
ByAinvest
Tuesday, Jan 6, 2026 4:26 am ET1min read
CBUS--
Cibus surged 10.64% in premarket trading following the announcement of a non-binding Letter of Intent (LOI) with Interoc to commercialize herbicide-tolerant (HT) rice traits across key Latin American markets. The agreement outlines plans for market entry in Ecuador and Colombia by 2027, with phased expansion into Peru, Central America, and the Caribbean. This partnership builds on a 2024 material transfer agreement where Cibus successfully integrated HT traits into Interoc’s rice germplasm. The LOI marks a strategic shift from R&D to commercial execution, positioning Cibus to license its gene-editing-derived traits for revenue generation. The move addresses urgent agricultural needs in Latin America, where weed resistance threatens yields, and aligns with Cibus’ focus on leveraging its Rapid Trait Development System™ to advance sustainable crop solutions.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet